Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Giral

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2016
Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant RecipientsM Yap, G Tilly, M Giral, et al.
Statistics in Medicine|October 11, 2025
A Noise-Tolerant Inference Procedure for Quasi-Monte Carlo Likelihood Estimation of a Joint Model for Multiple Longitudinal Markers and Competing RisksL Chabeau, P Rinder, S Desmée, et al.
Immunological Reviews|December 1, 1996
Synthetic peptides derived from human MHC class I sequences delay allograft rejection in rodents and inhibit cell-mediated cytotoxicity in vivo and in vitroM C Cuturi, R Josien, P Douillard, et al.
The New England Journal of Medicine|July 14, 1994
Membranous nephropathy and a TAP1 gene polymorphismD Chevrier, M Giral, V Braud, et al.
Annals of Physical and Rehabilitation Medicine|July 19, 2017
Looking at hospitalized persons throughout the prism of the handicapM Giral, B Boussat, F Lombard, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2025
Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipientsV Bonnemains, Y Foucher, P Tessier, et al.
Journal of Medicinal Chemistry|November 1, 1991
Design of potent linear PAF antagonistsJ Bartrolí, E Carceller, M Merlos, et al.
Drugs Under Experimental and Clinical Research|January 1, 1997
Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in ratsD Balsa, M Merlos, M Giral, et al.
Journal of Medicinal Chemistry|February 21, 1992
4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Lipid Mediators and Cell Signalling|September 26, 1997
Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediatorsD Balsa, M Merlos, M Giral, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2016
Benefits of Using CD45RA and CD28 to Investigate CD8 Subsets in Kidney Transplant RecipientsM Yap, G Tilly, M Giral, et al.
Statistics in Medicine|October 11, 2025
A Noise-Tolerant Inference Procedure for Quasi-Monte Carlo Likelihood Estimation of a Joint Model for Multiple Longitudinal Markers and Competing RisksL Chabeau, P Rinder, S Desmée, et al.
Immunological Reviews|December 1, 1996
Synthetic peptides derived from human MHC class I sequences delay allograft rejection in rodents and inhibit cell-mediated cytotoxicity in vivo and in vitroM C Cuturi, R Josien, P Douillard, et al.
The New England Journal of Medicine|July 14, 1994
Membranous nephropathy and a TAP1 gene polymorphismD Chevrier, M Giral, V Braud, et al.
Annals of Physical and Rehabilitation Medicine|July 19, 2017
Looking at hospitalized persons throughout the prism of the handicapM Giral, B Boussat, F Lombard, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2025
Predicting EQ-5D-3L utility values from clinical data in a prospective cohort of kidney transplant recipientsV Bonnemains, Y Foucher, P Tessier, et al.
Journal of Medicinal Chemistry|November 1, 1991
Design of potent linear PAF antagonistsJ Bartrolí, E Carceller, M Merlos, et al.
Drugs Under Experimental and Clinical Research|January 1, 1997
Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in ratsD Balsa, M Merlos, M Giral, et al.
Journal of Medicinal Chemistry|February 21, 1992
4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonistsE Carceller, M Merlos, M Giral, et al.
Journal of Lipid Mediators and Cell Signalling|September 26, 1997
Effect of endotoxin and platelet-activating factor on rat vascular permeability: role of vasoactive mediatorsD Balsa, M Merlos, M Giral, et al.
Pageof 8